Related references
Note: Only part of the references are listed.Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease
Young Woo Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Lipid Metabolism and Neuroinflammation in Alzheimer's Disease: A Role for Liver X Receptors
Jihong Kang et al.
ENDOCRINE REVIEWS (2012)
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease
Lakshman Puli et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Levels of Amyloid Beta-42, Interleukin-6 and Tumor Necrosis Factor-Alpha in Alzheimer's Disease and Vascular Dementia
Sema Uslu et al.
NEUROCHEMICAL RESEARCH (2012)
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling
Adam M. H. Young et al.
PLOS ONE (2012)
The role of inflammatory processes in Alzheimer’s disease
G. Joseph Broussard et al.
INFLAMMOPHARMACOLOGY (2012)
Effects of Compound Danshen tablets on spatial cognition and expression of brain β-amyloid precursor protein in a rat model of alzheimer's disease
Qin Ren-an et al.
JOURNAL OF TRADITIONAL CHINESE MEDICINE (2012)
Effects of Hericium erinaceus on amyloid β(25-35) peptide-induced learning and memory deficits in mice
Koichiro Mori et al.
BIOMEDICAL RESEARCH-TOKYO (2011)
Interleukin-6, a mental cytokine
Anneleen Spooren et al.
BRAIN RESEARCH REVIEWS (2011)
The Mechanism of Memory Impairment Induced by Aβ Chronic Administration Involves Imbalance between Cytokines and Neurotrophins in the Rat Hippocampus
C. Ji et al.
CURRENT ALZHEIMER RESEARCH (2011)
Ginkgolide B protects hippocampal neurons from apoptosis induced by beta-amyloid 25-35 partly via up-regulation of brain-derived neurotrophic factor
Qian Xiao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1
Dao-Yao He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Silibinin Attenuates Amyloid β25-35 Peptide-Induced Memory Impairments: Implication of Inducible Nitric-Oxide Synthase and Tumor Necrosis Factor-α in Mice
P. Lu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Kihi-to, a herbal traditional medicine, improves Abeta(25-35)-induced memory impairment and losses of neurites and synapses
Chihiro Tohda et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2008)
Effect of tanshinone on the levels of nitric oxide synthase and acetylcholinesterase in the brain of Alzheimer's disease rat model
You Yin et al.
CLINICAL AND INVESTIGATIVE MEDICINE (2008)
Protective effect of recombinant human somatotropin on amyloid β-peptide induced learning and memory deficits in mice
Fu Ai Ling et al.
GROWTH HORMONE & IGF RESEARCH (2007)
Effective pharmacologic management of Alzheimer's disease
Martin R. Farlow et al.
AMERICAN JOURNAL OF MEDICINE (2007)
The role of acetylcholine in learning and memory
Michael E. Hasselmo
CURRENT OPINION IN NEUROBIOLOGY (2006)
The use of herbal medicine in Alzheimer's disease - A systematic review
Leopoldo Luiz dos Santos-Neto et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2006)
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
R. Schliebs et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease
SY Peng et al.
JOURNAL OF NEUROCHEMISTRY (2005)
A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients
K Iwasaki et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Pharmacotherapy for Alzheimer's disease: progress and prospects
AM Palmer
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Applications of the Morris water maze in the study of learning and memory
R D'Hooge et al.
BRAIN RESEARCH REVIEWS (2001)
Neuroprotective and symptomatological action of memantine relevant for alzheimer's disease - a unified glutamatergic hypothesis on the mechanism of action
Wojciech Danysz et al.
NEUROTOXICITY RESEARCH (2000)
Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease
DL Bai et al.
CURRENT MEDICINAL CHEMISTRY (2000)
Share Paper
